These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 1689905)

  • 1. Pancreaticoduodenal allotransplantation with FK 506 in the cynomolgus monkey.
    Ericzon BG; Kubota K; Groth CG; Wijnen R; Tiebosch T; Buurman W; Kootstra G
    Transplant Proc; 1990 Feb; 22(1):72-3. PubMed ID: 1689905
    [No Abstract]   [Full Text] [Related]  

  • 2. Pancreaticoduodenal allotransplantation with FK 506 in the dog.
    Morimoto T; Yamada F; Kobayashi T; Miyaishi S; Tokumaru T; Kamiya I; Takagi H
    Transplant Proc; 1990 Apr; 22(2):717-9. PubMed ID: 1691550
    [No Abstract]   [Full Text] [Related]  

  • 3. Pancreaticoduodenal allotransplantation with the use of FK 506, cyclosporine, and triple-regimen immunosuppression.
    Imai K; Sato K; Takishima T; Nakayama Y; Osakabe T; Yokota K; Yamagishi K; Uchida H; Hiki Y
    Transplant Proc; 1990 Aug; 22(4):1655-7. PubMed ID: 1697117
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of FK 506 on glucose metabolism in the cynomolgus monkey: studies in pancreatic transplant recipients and nontransplanted animals.
    Ericzon BG; Wijnen RM; Kubota K; Kootstra G; Groth CG
    Transplant Proc; 1991 Feb; 23(1 Pt 1):511. PubMed ID: 1703695
    [No Abstract]   [Full Text] [Related]  

  • 5. Significance of pancreatic allograft rejection in swine abdominal organ cluster transplantation.
    Kobayashi N; Sakagami K; Takasu S; Inagaki M; Hasuoka H; Yagi T; Onoda T; Matsuno T; Saito S; Kawamura T
    Transplant Proc; 1991 Feb; 23(1 Pt 1):635-9. PubMed ID: 1703707
    [No Abstract]   [Full Text] [Related]  

  • 6. Histopathological study of canine pancreaticoduodenal allotransplantation with FK506, cyclosporine, and triple regimen immunosuppression.
    Imai K; Sato K; Nakayama Y; Takishima T; Osakabe T; Yokota K; Yamagishi K; Uchida H; Hiki Y; Kakita A
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1589-92. PubMed ID: 1703347
    [No Abstract]   [Full Text] [Related]  

  • 7. A potent immunosuppressive effect of FK 506 in orthotopic liver transplantation in primates.
    Monden M; Gotoh M; Kanai T; Valdivia LA; Umeshita K; Endoh W; Nakano Y; Kawai M; Ohzato H; Ukei T
    Transplant Proc; 1990 Feb; 22(1):66-71. PubMed ID: 1689904
    [No Abstract]   [Full Text] [Related]  

  • 8. Prolongation of pancreaticoduodenal allograft survival in rats by treatment with FK 506.
    Yamashita T; Maeda Y; Ishikawa T; Ohira M; Nakagawa H; Nagai Y; Park I; Yamamoto Y; Yoshikawa K; Cai R
    Transplant Proc; 1991 Dec; 23(6):3219-20. PubMed ID: 1721414
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of FK506 treatment on pancreaticoduodenal allotransplantation in the primate.
    Ericzon BG; Wijnen RM; Tiebosch A; Kubota K; Kootstra G; Groth CG
    Transplantation; 1992 Jun; 53(6):1184-9. PubMed ID: 1376501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pattern of rejection and susceptibility to different kinds of immunosuppression after combined liver, duodenum, and pancreas transplantation in swine--immunosuppressive drugs versus ex vivo immunomodulation of the allograft.
    Saito S; Fujiwara T; Sakagami K; Kobayashi N; Takaishi Y; Orita K
    Transplant Proc; 1995 Feb; 27(1):518-9. PubMed ID: 7533420
    [No Abstract]   [Full Text] [Related]  

  • 11. Initial experience with FK 506 as an immunosuppressant for nonhuman primate recipients of cardiac allografts.
    Flavin T; Ivens K; Wang J; Gutierrez J; Hoyt EG; Billingham M; Morris RE
    Transplant Proc; 1991 Feb; 23(1 Pt 1):531-2. PubMed ID: 1703701
    [No Abstract]   [Full Text] [Related]  

  • 12. Pancreaticoduodenal allotransplantation with cyclosporine and FK506.
    Sato K; Yamagishi K; Nakayama Y; Yokota K; Uchida H; Masaki Y; Watanabe K; Aso K
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1074-5. PubMed ID: 2468212
    [No Abstract]   [Full Text] [Related]  

  • 13. Characterization of the immunosuppressive activity of FK 506 in rat islet allografts.
    Yasunami Y; Ryu S; Kamei T
    Transplant Proc; 1990 Apr; 22(2):875. PubMed ID: 1691557
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevention of immune rejection in rat islet allografts by continuous SC administration of FK 506 using a mini-osmotic pump.
    Ryu S; Yasunami Y
    Transplant Proc; 1991 Feb; 23(1 Pt 1):760. PubMed ID: 1703710
    [No Abstract]   [Full Text] [Related]  

  • 15. Side effects of FK 506 in cynomolgus monkeys: a histopathologic study.
    Tiebosch A; Ericzon BG; Wijnen R; Arends JW; Groth CG; Kootstra G
    Transplant Proc; 1990 Aug; 22(4):1652. PubMed ID: 1697115
    [No Abstract]   [Full Text] [Related]  

  • 16. Reversal of ongoing rejection of allografts by rapamycin.
    Chen HF; Wu JP; Luo HY; Daloze PM
    Transplant Proc; 1991 Aug; 23(4):2241-2. PubMed ID: 1871859
    [No Abstract]   [Full Text] [Related]  

  • 17. The immunosuppressive effect of rapamycin on pancreaticoduodenal transplants in the rat.
    Chen HF; Wu JP; Luo HY; Daloze PM
    Transplant Proc; 1991 Aug; 23(4):2239-40. PubMed ID: 1714651
    [No Abstract]   [Full Text] [Related]  

  • 18. FK 506--an investigational immunosuppressant.
    Med Lett Drugs Ther; 1991 Oct; 33(854):94. PubMed ID: 1716722
    [No Abstract]   [Full Text] [Related]  

  • 19. Toxicity of FK 506 in the cynomolgus monkey: noncorrelation with FK 506 serum levels.
    Wijnen RM; Ericzon BG; Tiebosch AT; Beysens AJ; Groth CG; Kootstra G
    Transplant Proc; 1991 Dec; 23(6):3101-4. PubMed ID: 1721371
    [No Abstract]   [Full Text] [Related]  

  • 20. FK 506-based immunosuppression in clinical pancreas transplantation.
    Swanson C; Rubin M; Colquhoun S; Basadonna G; Asshinnik A; Perez R
    Transplant Proc; 1995 Dec; 27(6):3031. PubMed ID: 8539827
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.